Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hammond

Showing results (551-560 of 711) with videos related to

Pageof 72
Sort By:
Kidney International|October 22, 2015
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney diseaseChristopher L Newman, Amy Creecy, Mathilde Granke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two yearsStuart M Flechner, Sunil M Kurian, Kim Solez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignanciesE K Rowinsky, R Humphrey, L A Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignanciesEric K Rowinsky, Jinee Rizzo, Leonel Ochoa, et al.
Plos One|May 11, 2012
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEALi Peng, Michael D Oberst, Jiaqi Huang, et al.
Infectious Diseases|October 8, 2020
Vancomycin Dosing Practices among Critical Care Pharmacists: A Survey of Society of Critical Care Medicine PharmacistsAlexander H Flannery, Drayton A Hammond, Douglas R Oyler, et al.
Discovery Immunology|June 3, 2026
Profiling of porcine B-cell receptor heavy-chain repertoires indicates the development of a wide public pseudorabies virus-specific immune response after vaccination and challengeValentin Herbet, Edouard Hirchaud, Yannick Blanchard, et al.
Pharmacotherapy|November 3, 2016
The 2016 ACCP Pharmacotherapy Didactic Curriculum ToolkitTerry L Schwinghammer, Andrew J Crannage, Eric G Boyce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect studyEmiliano Calvo, Anthony W Tolcher, Lisa A Hammond, et al.
The Journal of General Virology|July 29, 2020
Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virusSarah Keep, Michael S Oade, Filip Lidzbarski-Silvestre, et al.
Pageof 72

Showing results (551-560 of 711) with videos related to

Sort By:
Pageof 72
Kidney International|October 22, 2015
Raloxifene improves skeletal properties in an animal model of cystic chronic kidney diseaseChristopher L Newman, Amy Creecy, Mathilde Granke, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two yearsStuart M Flechner, Sunil M Kurian, Kim Solez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase I and pharmacologic study of the specific matrix metalloproteinase inhibitor BAY 12-9566 on a protracted oral daily dosing schedule in patients with solid malignanciesE K Rowinsky, R Humphrey, L A Hammond, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
A phase I and pharmacokinetic study of pegylated camptothecin as a 1-hour infusion every 3 weeks in patients with advanced solid malignanciesEric K Rowinsky, Jinee Rizzo, Leonel Ochoa, et al.
Plos One|May 11, 2012
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEALi Peng, Michael D Oberst, Jiaqi Huang, et al.
Infectious Diseases|October 8, 2020
Vancomycin Dosing Practices among Critical Care Pharmacists: A Survey of Society of Critical Care Medicine PharmacistsAlexander H Flannery, Drayton A Hammond, Douglas R Oyler, et al.
Discovery Immunology|June 3, 2026
Profiling of porcine B-cell receptor heavy-chain repertoires indicates the development of a wide public pseudorabies virus-specific immune response after vaccination and challengeValentin Herbet, Edouard Hirchaud, Yannick Blanchard, et al.
Pharmacotherapy|November 3, 2016
The 2016 ACCP Pharmacotherapy Didactic Curriculum ToolkitTerry L Schwinghammer, Andrew J Crannage, Eric G Boyce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2004
Administration of CI-1033, an irreversible pan-erbB tyrosine kinase inhibitor, is feasible on a 7-day on, 7-day off schedule: a phase I pharmacokinetic and food effect studyEmiliano Calvo, Anthony W Tolcher, Lisa A Hammond, et al.
The Journal of General Virology|July 29, 2020
Multiple novel non-canonically transcribed sub-genomic mRNAs produced by avian coronavirus infectious bronchitis virusSarah Keep, Michael S Oade, Filip Lidzbarski-Silvestre, et al.
Pageof 72